Botulinum A toxin therapy on esotropia in children

Journal of the Medical Association of Thailand

Volumn 85, Issue 11, 2002, Pages 1189-1197

  Tengtrisorn, Supaporn ^a   Treyapun, Nuntaporn ^b   Tantisarasart, Thawat ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Botulinum A toxin; Children; Esotropia

Indexed keywords

BOTULINUM TOXIN A;

AMBLYOPIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVAL HEMORRHAGE; CONVERGENT STRABISMUS; DRUG EFFICACY; FEMALE; HUMAN; MALE; PTOSIS;

BOTULINUM TOXIN TYPE A; CHILD, PRESCHOOL; COHORT STUDIES; ESOTROPIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; OCULOMOTOR MUSCLES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THAILAND; TREATMENT OUTCOME;

EID: 0036881373     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. nd edition. Blackwell Science Ltd. 1997: 925-36.
2. Helvesten EM. The origins of congenital esotropia. J Pediatr Ophthalmol Strabismus 1993; 30: 215-32.
3. Hiles DA, Watson BA, Biglan AW. Characteristics of infantile esotropia following early bimedial rectus recession. Arch Ophthalmol 1980; 98: 697-703.
4. Scott AB, Magoon EH, McNeer KW. Botulinum treatment of childhood strabismus. Ophthalmology 1990; 97: 1434-8.
5. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044-9.
6. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981; 79: 734-70.
7. Ing MR. Botulinum alignment for congenital esotropia. Ophthalmology 1993; 100: 318-22.
8. McNeer KW, Tucker MG, Spencer RF. Botulinum toxin management of essential infantile esotropia in children. Arch Ophthalmol 1997; 115: 1411-8.
9. Biglan AW, Burnstine RA, Rogers GL, Saunders RA. Management of strabismus with Botulinum A toxin. Ophthalmology 1989; 96: 935-43.
10. Campos EC, Schiavi C, Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J Pediatr Ophthalmol Strabismus 2000; 37: 328-32.
11. Abbasoglu OE, Sener EC, Sanac AS. Factors influencing success and dose-effect relation of botulinum A treatment. Eye 1996; 10: 385-91.
12. Harris CP, Alderson K, Nebeker J, Holds JB, Anderson RL. Histologic features of human orbicularis oculi treated with botulinum a toxin. Arch Ophthalmol 1991; 109: 393-5.
13. American Academy of Ophthalmology. Botulinum toxin therapy of eye muscle disorders: safety and effectiveness. Ophthalmology 1989; 96: 37-41.
14. Magoon E, Scott AB. Botulinum toxin chemodenervation in infant and children: An alternative to incisional strabismus surgery. J Pediatr 1987; 110: 719-22.
15. Magoon EH. Chemodenervation of strabismic children: A 2 to 5 year follow-up study compared with shorter follow-up. Ophthalmology 1989; 96: 931-4.
16. McNeer KW, Tucker MG, Spencer RF. Management of essential infantile esotropia with botulinum toxin A: Review and recommendations. J Pediatr Ophthalmol Strabismus 2000; 37: 61-7.
17. Han SH, Lew H, Jeong CW, Lee JB. Effect of botulinum toxin A chemicaldenervation in sensory strabismus. J Pediatr Ophthalmol Strabismus 2001; 38: 68-71.